An Observational Study of Patients With Chronic Kidney Disease


TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 2037


  • Other: Observational
    • Observational

Arms, Groups and Cohorts

  • Disease Cohort
  • Engaged Cohort

Clinical Trial Outcome Measures

Primary Measures

  • To characterize the natural history of disease in patients with CKD/ESKD
    • Time Frame: 20 Years
  • To assess safety and effectiveness of CKD/ESKD treatments and treatments for complications of either condition
    • Time Frame: 20 Years

Secondary Measures

  • To evaluate provider management practices in the treatment of patients with CKD/ESKD
    • Time Frame: 20 Years
  • To evaluate longitudinal and patient reported outcomes in CKD/ESKD
    • Time Frame: 20 Years
  • To select and evaluate quality of care measures for patients with CKD/ESKD
    • Time Frame: 20 Years

Participating in This Clinical Trial

Disease Cohort Inclusion Criteria:

  • Adult* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface Exclusion Criteria:

  • Death – Manual removal (sponsor or site request) – No EHR interface encounter > 3 years Engaged Cohort Inclusion Criteria:

  • Adult * patients diagnosed and managed for CKD/ESKD invited to participate – Ability to provide written informed consent Exclusion Criteria:

  • Patient expressed desire to withdraw consent to complete PROs – Failure to complete PROs within 24 weeks of initial invitation – Greater than 24 months lapse of survey completion after baseline surveys completed – Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Target PharmaSolutions, Inc.
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.